Group Hypnosis for Stress Reduction - a Feasibility Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Cohens Perceived Stress Scale 10 Items
Study Overview
Brief Summary
This prospective feasibility study aims to test a 5 week group hypnosis training as intervention to reduce perceived psychological stress in healthy subjects.
Detailed Description
In a pre- post comparison the feasibility of a standardized weekly 90 minutes group hypnosis training including CDs/MP3 recordings as homework to reduce perceived psychological stress in healthy subjects is investigated. Outcomes are measured quantitatively and qualitatively.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Healthy or health-stable participants between 18 and 70 years with subjective increased intensity of stress in the last four weeks on the visual analogue scale rated between 40 -100 mm (VAS 0 - 100 mm)
- •Ability to consent and sign declaration of informed consent
Exclusion Criteria
- •Current or planned participation in a stress management program within the next 17 weeks
- •Current use of psychotherapeutic treatment
- •presence of moderate or severe acute or chronic disease
- •presence of an acute or chronic mental disorder
- •Participation in a study within the last 2 months prior to enrollment
- •Lack of understanding of the German language
Arms & Interventions
Group Hypnosis
5 sessions of group hypnosis, each 90 minutes; plus CDs/MP3 recordings to train at home
Intervention: Group hypnosis (Behavioral)
Outcomes
Primary Outcomes
Cohens Perceived Stress Scale 10 Items
Time Frame: 5 weeks
Likert-Skala
Time Frame: 5 weeks
about stressreduction
ADS-K (Depression)
Time Frame: 5 weeks
SF 36 Quality of Life
Time Frame: 5 weeks
Perceived Stress on Visual Analogue Scale
Time Frame: 5 weeks
VAS 0-100 mm
General Self Efficacy Scale (Schwarzer)
Time Frame: 5 weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
Benno Brinkhaus
Prof. Dr. med.
Charite University, Berlin, Germany